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SUMMARY. A series of novel danshensu amide derivatives were synthesized, and the protective effects of all
the compounds on rat myocardial cell lines H9C2 by hypoxia were investigated. The results showed that all the
seven compounds could significantly increased cell viability compared with hypoxia group. Among these com-
pounds, 3-(3,4-dimethoxyphenyl)-2-hydroxy-N-propylpropanamide (6) exhibited good activities, with cell via-
bility reached 94.2 % compared to the normal. The novel danshensu amide derivatives, possessing an additional
lipophilic alkyl chain showed a good lipophilicity.
